Adverse outcomes of ERCP

Gastrointestinal Endoscopy

Volumn 56, Issue SUPPL. 6, 2002, Pages

  Freeman, Martin L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; GABEXATE; NONIONIC CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; SOMATOSTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

BLEEDING; CARDIOVASCULAR DISEASE; CHOLANGITIS; CHOLECYSTITIS; CHOLELITHIASIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXPERIENCE; HUMAN; IATROGENIC DISEASE; LUNG COMPLICATION; PANCREATITIS; PERFORATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SPHINCTEROTOMY; SURGICAL TECHNIQUE; TRAINING; TREATMENT OUTCOME;

BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; EVIDENCE-BASED MEDICINE; HUMANS; PANCREATIC DISEASES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT FAILURE;

EID: 0037000785     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.129028     Document Type: Conference Paper

References (103)

1. Classen M, Demling L. Endoskopische sphinkterotomie der papilla vateri und steinextraktion aus dem ductus choledochus (German). Dtsch Med Wochenschr 1974;99:496-7.
2. Kawai K, Akasaka Y, Murakami K, Tada M, Kohli Y, Nakajima M. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc 1974;20:148-51.
3. Aliperti G, Edmundowicz SA, Soper NJ, Ashley SW. Combined endoscopic sphincterotomy and laparoscopic cholecystectomy in patients with choledocholithiasis and cholecystolithiasis. Ann Intern Med 1991;115:783-5.
4. Strasberg SM, Soper NJ. Management of choledocholithiasis in the laparoscopic era. Gastroenterology 1995;109:320-1.
5. Cotton PB, Chung SC, Davis WZ, Gibson RM, Ransohoff DF, Strasberg SM. Issues in cholecystectomy and management of duct stones. Am J Gastroenterol 1994;89:S169-76.
6. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35:467-70.
7. Pereira-Lima JC, Jakobs R, Maier M, Benz C, Kohler B, Riemann JF. Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol 1996;91:2179-84.
8. Sherman S, Lehman GA. Endoscopic therapy of pancreatic disease. Gastroenterologist 1997;5:262-77.
9. Lehman GA, Sherman S. Sphincter of Oddi dysfunction. Int J Pancreatol 1996;20:11-25.
10. Cotton PB, Lehman G, Vennes JA, Geenen JE, Russell RCG, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-91.
11. Ostroff JW, Shapiro HA. Complications of endoscopic sphincterotomy. In: Jacobsen IM, editor. ERCP: diagnostic and therapeutic applications. New York: Elsevier Science Publications; 1989. p. 61-73.
12. Hawes RH, Cotton PB, Vallon AG. Follow up 6 to 11 years after duodenoscopic sphincterotomy for stones in patients with prior cholecystectomy. Gastroenterology 1990;98:1008-12.
13. Prat F, Malak MA, Pelletier G. Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis. Gastroenterology 1996;110:894-9.
14. Bergman JJ, van der Mey S, Rauws EA, Tijssen JG, Gouma DJ, Tytgat G, et al. Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc 1996;44:643-9.
15. May GR, Cotton PB, Edmunds EJ. Removal of stones from the bile duct at ERCP without sphincterotomy. Gastrointest Endosc 1993;396:749-51.
16. MacMathuna P, White P, Clarke E, Merriman R, Lennon JR, Crowe J. Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc 1995;42:468-74.
17. Hunter JG, Soper NJ. Laparoscopic management of bile duct stones. Surg Clin North Am 1992;72:1077-97.
18. Silvis SE. Endoscopic sphincterotomy with an intact gallbladder. Gastrointest Endosc Clin N Am 1991;1:65-77.
19. Cotton PB. Outcomes of endoscopy procedures: struggling towards definitions. Gastrointest Endosc 1994;40:514-8.
20. Fleischer DE. Better definition of endoscopic complications and other negative outcomes. Gastrointest Endosc 1994;40:511-4.
21. Freeman ML, Nelson DB, Snady HW, DiSario JA, Overby CS, Ryan ME, et al. Failures and complications of ERCP: impact on procedural outcome and resource utilization [abstract]. Am J Gastroenterol 1997;92:1634.
22. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
23. Gottlieb K, Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998;8:87-114.
24. Newcomer MK, Jowell PS, Cotton PB. Underestimation of adverse events following ERCP: a prospective 30 day followup study [abstract]. Gastrointest Endosc 1995;41:408.
25. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non dilated bile ducts. Gastroenterology 1991;101:1068-75.
26. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with non dilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994;89:327-33.
27. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997;29:252-7.
28. Wilson MS, Tweedle DE, Martin DF. Common bile duct diameter and complications of endoscopic sphincterotomy. Br J Surg 1992;79:1346-7.
29. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 1997;46:217-22.
30. Dickinson RJ, Davies S. Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient. Eur J Gastroenterol Hepatol 1998;10:423-8.
31. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201-10.
32. Leese T, Neoptolemos JP, Carr-Locke DL. Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg 1985;72:215-9.
33. Vaira D, D'Anna L, Ainley C, Dowsett J, Williams S, Baillie J, et al. Endoscopic sphincterotomy in 1000 consecutive patients. Lancet 1989;2:431-4.
34. Classen M. Endoscopic papillotomy. In: Sivak MV Jr, editor. Gastroenterologic endoscopy. Philadelphia: WB Saunders; 1987. p. 631-51.
35. Sherman S, Lehman GA. Complications of endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy. In: Barkin J, O'Phelan CA, editors. Advanced therapeutic endoscopy. New York: Raven Press; 1990. p. 201-10.
36. Moreira VF, Arribas R, Sanroman AL. Choledocholithiasis in cirrhotic patients: is endoscopic sphincterotomy the safest choice? Am J Gastroenterol 1991;86:1006-10.
37. Boender J, Nix GA, de Ridder MA, van Blankenstein M, Schutte HE, Dees J, et al. Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate. Endoscopy 1994;26:209-16.
38. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
39. Neoptolemos JP, Shaw DE, Carr-Locke DL. A multivariate analysis of perioperative risk factors in patients with common bile duct stones. Ann Surg 1989;209:157-61.
40. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
41. Lai EC, Lo CM, Choi TK, Cheng WK, Fan ST, Wong J. Urgent biliary decompression after endoscopic retrograde cholangiopancreatography. Am J Surg 1989;157:121-5.
42. Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol 1999;94:387-90.
43. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96:417-23.
44. Mehta SN, Pavone E, Barkun JS, Bouchard S, Barkun AN. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998;30:457-63.
45. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-81.
46. Rabenstein T, Schneider HT, Bulling D, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 2000;32:10-9.
47. Tzovaras G, Shukla P, Kow L, Mounkley D, Wilson T, Toouli J. What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography? Aust N Z J Surg 2000;70:778-82.
48. Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol 1994;19:283-7.
49. Freeman ML. Sedation and monitoring for gastrointestinal endoscopy. In: Yamada T, editor. Textbook of gastroenterology. Philadelphia: Lippincott, Williams, and Wilkins; 1999. p. 2655-67.
50. Geenen JE, Hogan WJ, Dodds WJ, Touli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989;320:82-7.
51. Kozarek RA. Biliary dyskinesia: Are we any closer to defining the entity? Gastrointest Endosc Clin N Am 1993;3:167-78.
52. Hogan WJ. Stenting the pancreas: is this the solution to post-ERCP pancreatitis? Gastroenterology 1998;115:1591-4.
53. Rolny P, Anderberg B, Ishe I, Lindstrom E, Olaison G, Arvill A. Pancreatitis after sphincter of Oddi manometry. Gut 1990;31:821-4.
54. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990;36:462-6.
55. Freeman ML. Precut (access) sphincterotomy. Tech Gastrointest Endosc 1999;1:40-8.
56. Cotton PB. Precut papillotomy: a risky technique for experts only. Gastrointest Endosc 1989;35:578-9.
57. Vandervoort J, Carr-Locke DL. Needle-knife access papillotomy: an unfairly maligned technique? Endoscopy 1996;28:365-6.
58. Huibregtse K, Katon RM, Tytgat GN. Precut papillotomy via fine needle-knife papillotome: a safe and effective technique. Gastrointest Endosc 1986;32:403-5.
59. Gholson CF, Favrot D. Needle-knife papillotomy in a university referral practice. Safety and efficacy of a modified technique. J Clin Gastroenterol 1996;23:177-80.
60. Binmoeller KF, Seifert H, Gerke H, Seitz U, Portis M, Soehendra N. Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve bile duct cannulation. Gastrointest Endosc 1996;44:689-95.
61. Foutch PG. A prospective assessment of results for needleknife papillotomy and standard endoscopic sphincterotomy. Gastrointest Endosc 1995;41:25-32.
62. Kasmin FE, Cohen D, Batra S, Cohen SA, Siegel JH. Needleknife sphincterotomy in a tertiary referral center: efficacy and complications. Gastrointest Endosc 1996;44:48-53.
63. Slot WB, Schoeman MN, DiSario JA, Wolters F, Tytgat GNJ, Huibregtse K. Needle-knife sphincterotomy as a pre-cut procedure - a retrospective evaluation of efficacy and complications. Endoscopy 1996;28:334-9.
64. Sherman S, Hawes R, Earle D, Baute P, Bucksot L, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study [abstract]. Gastrointest Endosc 1996;43:413.
65. Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999;31:125-30.
66. Alnounou M, Sherman S, Fogel E, Gottlieb K, Ness R, Phillips S, et al. The significance of serum alpha-1-antitrypsin level in post-ERCP pancreatitis according to risk stratification of patient and procedure [abstract]. Gastrointest Endosc 1999;49:AB70.
67. Tarnasky, P, Palesch, Y, Cunningham J, Maulsin P, Cotton P, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
68. Patel R, Tarnasky PR, Hennessy WS, Hawes, RH, Payne KM, Nelles SE, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective, randomized trial [abstract]. Gastrointest Endosc 1999;49:AB80.
69. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001;54:209-13.
70. Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993;39:652-7.
71. Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990;36:93-5.
72. Smith MT, Sherman S, Ikenberry SO, Hawes RH, Lehman GA. Alternations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996;44:268-75.
73. Bergman JJ, Rauws EA, Fockens P, van Berkel AM, Bossuyt PM, Tijssen JG, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997;349:1124-9.
74. Ochi Y, Mukawa K, Kiyosawa, Akamatsu T. Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol 1999;14:90-6.
75. DiSario JA, Freeman ML, Bjorkman DJ, MacMathuna P, Petersen B, Sherman S, et al. Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: preliminary results [abstract]. Gastrointest Endosc 1997;45:AB129.
76. Schwaca SM, Allgaier HP, Deibert P, Olschewski M, Allgaier U, Blum HE. A sphincterotome-based technique for selective trasnspapillary common bile duct cannulation. Gastroenterology 2000;52:387-91.
77. Cortas GA, Mehta SN, Abraham NS, Barkun AN. Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes. Gastrointest Endosc 1999;50:775-9.
78. Siegel JH, Veerappen A, Tucker R. Bipolar versus monopolar sphincterotomy: a prospective trial. Am J Gastroenterol 1994;89:1827-30.
79. Elta GH, Barnett JL, Wille RT, Brown KA, Chey WD, Scheiman JM. Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current. Gastrointest Endosc 1998;47:149-53.
80. Perini RF, Sadurski R, Hawes RH, Payne KM, Cotton PB, Cunningham JT, et al. Does the ERBE generator influence the incidence of post-sphincterotomy pancreatitis in patients with sphincter of Oddi dysfunction? An analysis of 560 patients [abstract]. Gastrointest Endosc 2001;53:AB61.
81. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
82. Deviere J, Le Moine O, Van Laethem J, Eisendrath P, Ghilain A, Severs N et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
83. Johnson GK, Geenen JE, Bedford RA. A comparison of non-ionic versus ionic contrast media: results of a prospective, multicenter study. Gastrointest Endosc 1995;42:312-6.
84. Budzynska A, Marek T, Nowak A, Kaczor R, NowakowskaDulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-72.
85. Sahai AV, Kay CK, Hoffman BJ. Nonendoscopic retrograde cholangiopancreatography diagnosis of bile duct stones. Tech Gastrointest Endosc 1999;1:7-11.
86. Freeman ML, Nelson DB, Sherman S, Haber GB, Fennerty MB, DiSario JA, et al. Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complications study. Gastrointest Endosc 1999;49:580-6.
87. Leung JWC, Chan FKL, Sung JJY, Chung S. Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection. Gastrointest Endosc 1995;42:550-4.
88. Mellinger JD, Ponsky JL. Bleeding after endoscopic sphincterotomy as an underestimated entity. Surg Gynecol Obstet 1991;172:465-9.
89. Qaseem T, Howell DA, Elton E, Parsons WG. Prevention of post endoscopic sphincterotomy (ES) bleeding: is epinephrine usage safe? [abstract]. Am J Gastroenterol 1996;91:1940.
90. Catalano MF, Geenen JE, Johnson GK, Schmalz MJ, Kaikaus R, Hogan WJ. Endoscopic sphincterotomy in patients at high risk for gastrointestinal (GI) hemorrhage: a new technique [abstract]. Gastrointest Endosc 1995;41:392.
91. Sherman S, Hawes RH, Nisi R, Lehman GA. Endoscopic sphincterotomy-induced hemorrhage: treatment with multipolar electrocoagulation. Gastrointest Endosc 1992;38:123-6.
92. Harris A, Chan AC, Torres-Viera C, Hammett R, Carr-Locke D. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31:718-24.
93. Silvis SE. Endoscopic sphincterotomy with an intact gallbladder. Gastrointest Endosc Clin N Am 1991;1:65-77.
94. Hill J, Martin DF, Tweedle DE. Risks of leaving the gallbladder in situ after endoscopic sphincterotomy for bile duct stones. Br J Surg 1991;78:554-7.
95. Shakoor T, Geenen JE. Pre-cut papillotomy. Gastrointest Endosc 1992;38:623-7.
96. Cotton PB. Is your sphincterotomy really safe - and necessary? Gastrointest Endosc 1996;44:752-5.
97. Asburn HJ, Rossi RL, Heiss FW, Shea JA. Acute relapsing pancreatitis as a complication of papillary stenosis after endoscopic sphincterotomy. Gastroenterology 1993;104:1814-7.
98. Geenen JE, Touli J, Hogan WJ. Endoscopic sphincterotomy: follow-up evaluation of effects on the sphincter of Oddi. Gastroenterology 1984;87:754-8.
99. Jowell PS, Baillie J, Branch S, Affronti J, Browning CL, Bute BP. Quantitative assessment of procedural competence: a prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med 1996;125:983-9.
100. Watkins JL, Etzkorn KP, Wiley TE, DeGuzman L, Harig JM. Assessment of technical competence during ERCP training. Gastrointest Endosc 1996;44:411-5.
101. American Society for Gastrointestinal Endoscopy. Methods of granting hospital privileges to perform gastrointestinal endoscopy. Gastrointest Endosc 2002;55:780-3.
102. Wigton RS. Measuring procedural skills. Ann Intern Med 1996;125:1003-4.
103. Huibregtse K. Complications of endoscopic sphincterotomy and their prevention. N Engl J Med 1996;335:961-2.